These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32976746)

  • 1. Communicating sickle cell disease point-of-care testing results.
    Jaja C; Gibson RW; Edem-Hotah J
    Lancet Haematol; 2020 Oct; 7(10):e708-e709. PubMed ID: 32976746
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
    Nnodu OE; Sopekan A; Nnebe-Agumadu U; Ohiaeri C; Adeniran A; Shedul G; Isa HA; Owolabi O; Chianumba RI; Tanko Y; Iyobosa JH; Adekile AD; Olopade OI; Piel FB
    Lancet Haematol; 2020 Jul; 7(7):e534-e540. PubMed ID: 32589979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening infants for sickle cell disease in sub-Saharan Africa: starting the journey to a sustainable model in primary care.
    Streetly A
    Lancet Haematol; 2020 Jul; 7(7):e503-e504. PubMed ID: 32589971
    [No Abstract]   [Full Text] [Related]  

  • 4. Capacity building and networking to make newborn screening for sickle cell disease a reality in Haiti.
    Saint Fleur R; Archer N; Hustace T; Louis RJ; Bellevue R; Gautier J; Lerebours E; Voltaire M; Alvarez O
    Blood Adv; 2018 Nov; 2(Suppl 1):54-55. PubMed ID: 30504202
    [No Abstract]   [Full Text] [Related]  

  • 5. Newborn Screening With Sickle Cell Point of Care: A Valuable Resource in Low-Income Settings.
    Ware RE; Odame I
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530718
    [No Abstract]   [Full Text] [Related]  

  • 6. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
    Alvarez OA; Hustace T; Voltaire M; Mantero A; Liberus U; Saint Fleur R
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn screening in Nigeria: Associating the screening of congenital hypothyroidism and sickle cell disease can be a winning choice?
    Yarhere IE; Jaja T; Briggs D; Iughetti L
    Acta Biomed; 2019 May; 90(2):316-320. PubMed ID: 31125012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges.
    Nnodu O; Isa H; Nwegbu M; Ohiaeri C; Adegoke S; Chianumba R; Ugwu N; Brown B; Olaniyi J; Okocha E; Lawson J; Hassan AA; Diaku-Akinwumi I; Madu A; Ezenwosu O; Tanko Y; Kangiwa U; Girei A; Israel-Aina Y; Ladu A; Egbuzu P; Abjah U; Okolo A; Akbulut-Jeradi N; Fernandez M; Piel FB; Adekile A
    Blood Cells Mol Dis; 2019 Sep; 78():22-28. PubMed ID: 30773433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal screening for sickle cell disease in France: evaluation of the selective process.
    Thuret I; Sarles J; Merono F; Suzineau E; Collomb J; Lena-Russo D; Levy N; Bardakdjian J; Badens C
    J Clin Pathol; 2010 Jun; 63(6):548-51. PubMed ID: 20498028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary care follow-up of newborns with sickle cell disease detected in neonatal screening in the Community of Madrid].
    Rodríguez-Moldes B; Carbajo AJ; Sánchez B; Fernández M; Garí M; Fernández MC; Álvarez J; García A; Cela E
    An Pediatr (Barc); 2015 Apr; 82(4):222-7. PubMed ID: 24840253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neonatal screening for sickle cell anemia in metropolitan France. For the group for neonatal screening of sickle cell anemia of the French Association for Screening and Prevention of Infant Handicaps (AFDPHE)].
    Galactéros F
    Pathol Biol (Paris); 1999 Jan; 47(1):13-8. PubMed ID: 10081774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
    Steele C; Sinski A; Asibey J; Hardy-Dessources MD; Elana G; Brennan C; Odame I; Hoppe C; Geisberg M; Serrao E; Quinn CT
    Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].
    Diallo DA; Guindo A; Touré BA; Sarro YS; Sima M; Tessougué O; Baraika MA; Guindo P; Traoré M; Diallo M; Dorie A
    Rev Epidemiol Sante Publique; 2018 May; 66(3):181-185. PubMed ID: 29625861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Newborn screening for sickle cell anemia].
    Dulín-Iñiguez E
    Med Clin (Barc); 2006 Mar; 126(8):293-4. PubMed ID: 16527156
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sickle cell disease in the neonatal period].
    de Montalembert M
    J Gynecol Obstet Biol Reprod (Paris); 2004 Feb; 33(1 Suppl):S12-4. PubMed ID: 14968012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study.
    Smart LR; Ambrose EE; Raphael KC; Hokororo A; Kamugisha E; Tyburski EA; Lam WA; Ware RE; McGann PT
    Ann Hematol; 2018 Feb; 97(2):239-246. PubMed ID: 29147848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn screening for sickle cell disease in a Nigerian hospital.
    Odunvbun ME; Okolo AA; Rahimy CM
    Public Health; 2008 Oct; 122(10):1111-6. PubMed ID: 18486954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary Evaluation of a Point-of-Care Testing Device (SickleSCAN™) in Screening for Sickle Cell Disease.
    Nwegbu MM; Isa HA; Nwankwo BB; Okeke CC; Edet-Offong UJ; Akinola NO; Adekile AD; Aneke JC; Okocha EC; Ulasi T; Abjah U; Ugwu NI; Okolo AA; Madu A; Emodi I; Girei A; Balogun TM; Diaku-Akinwumi IN; Ohiaeri C; Brown BJ; Olaniyi JA; Hassan A; Awwalu S; Okoh DA; Nnodu OE
    Hemoglobin; 2017 Mar; 41(2):77-82. PubMed ID: 28617057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a novel point of care testing device for sickle cell disease.
    Kanter J; Telen MJ; Hoppe C; Roberts CL; Kim JS; Yang X
    BMC Med; 2015 Sep; 13():225. PubMed ID: 26377572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Sickle Cell Trait and Reliability of Self-Reported Status among Expectant Parents in Nigeria: Implications for Targeted Newborn Screening.
    Burnham-Marusich AR; Ezeanolue CO; Obiefune MC; Yang W; Osuji A; Ogidi AG; Hunt AT; Patel D; Ezeanolue EE
    Public Health Genomics; 2016; 19(5):298-306. PubMed ID: 27614873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.